Search This Blog

Tuesday, December 8, 2015

New Analyses Presented At ASH 2015 Demonstrate The Potential Of Kyprolis® (Carfilzomib) As Backbone Therapy In Multiple Myeloma

Data Confirm Efficacy and Safety of Kyprolis Combination Across Range of Patient Populations



Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.